Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

<ul><li><keyword id="6354427" type="General" weightage="100" keywordseo="apple" source="Orion">Apple</keyword> is working on noninvasive blood glucose testing tech for its watch.</li><li>Also, <keyword id="1577486" type="General" weightage="20" keywordseo="Apple-Watch" source="Orion">Apple Watch</keyword> researchers explore new frontiers in heart health.</li></ul>Apple is a leader in smart wearable tech, and consistently refining and enhancing its Watch series to break the barriers. As per a recent <a href="https://www.bloomberg.com/news/articles/2023-02-22/apple-watch-blood-glucose-monitor-could-revolutionize-diabetes-care-aapl#xj4y7vzkg">report</a> by Bloomberg's <keyword id="2359925" type="General" weightage="50" keywordseo="mark-gurman" source="Orion">Mark Gurman</keyword>, Apple has achieved significant advancements in non-invasive blood glucose monitoring technology. The company plans to integrate this feature into future Apple Watch models, enabling diabetics and other users to check their blood glucose levels without skin pricking or blood testing. Furthermore, an <a href="https://www.apple.com/newsroom/2023/02/with-apple-watch-researchers-explore-new-frontiers-in-heart-health/">article</a> released by Apple showcased the groundbreaking efforts of health researchers worldwide who are utilizing the Apple Watch to explore new approaches to studying the heart. <cmsannotation type="cmsannotation" annotationid="Apple's noninvasive blood glucose technology" comment="subhead" text="Apple's noninvasive blood glucose technology">Apple's noninvasive blood glucose technology</cmsannotation> Apple is working on a silicon photonics chip that utilizes optical absorption spectroscopy to shine light from a laser through the skin to determine glucose concentration levels in the body without the need for blood. While the technology is in a "proof-of-concept" phase, it is currently the size of an iPhone and can be affixed to an individual's arm. Apple collaborated with TSMC to create the primary chip for the prototype but previously partnered with <keyword id="10958888" type="General" weightage="50" keywordseo="rockley-photonics" source="Orion">Rockley Photonics</keyword> to design sensors and chips for glucose monitoring. Rockley Photonics, which listed Apple as its primary customer in regulatory filings, unveiled a digital sensor system in 2021 that could track body temperature, blood pressure, glucose trends, hydration, lactate, alcohol, and other metrics. However, Apple terminated the relationship. The technology needs to be condensed to a wearable size to be practical. <cmsannotation type="cmsannotation" annotationid="Apple Watch ECG app to detect abnormal heart rhythms" comment="subhead" text="Apple Watch ECG app to detect abnormal heart rhythms"><keyword id="6875860" type="General" weightage="50" keywordseo="apple-watch-ecg" source="Orion">Apple Watch ECG</keyword> app to detect abnormal heart rhythms</cmsannotation> Researchers at the Murdoch Children’s Research Institute in Melbourne, including Associate Professor Rachel Conyers and Dr. Claudia Toro, are studying the toxicities of children’s cancer treatments and their effects on heart rhythm. They aim to identify novel interventions to mitigate these effects. To this end, Dr. Conyers and her team will be testing the sensitivity of the Apple Watch ECG app in 40 children and adolescents over the coming months. The researchers plan to enable patients to take ECGs anytime and anywhere using the app and other tools. By gathering these data, they hope to gain insights into cardiac toxicity and identify opportunities for intervention. The study can potentially improve the care of young cancer patients by helping clinicians monitor their heart health more closely and intervene early if necessary. The study aims to monitor a range of health factors, including heart rate, rhythm, and sleep, blood oxygen levels and other metrics. SEE ALSO: <a href="https://www.businessinsider.in/tech/news/google-chrome-rolls-out-memory-and-energy-saver-modes-heres-how-you-can-use-it/articleshow/98118135.cms">Google Chrome rolls out Memory and Energy Saver modes: Here’s how you can use it</a> <a href="https://www.businessinsider.in/tech/news/oneplus-11-concept-video-reveals-a-large-camera-and-a-rear-panel-that-lights-up/articleshow/98112845.cms">OnePlus 11 Concept video reveals a large camera and a rear panel that lights up</a>

Noninvasive blood glucose testing is among the new Apple Watch tech that reportedly reaches 'Proof-of Concept' stage

<ul class="summary-list"><li><keyword id="10958888" type="UNKNOWN" weightage="60" keywordseo="Rockley-Photonics">Rockley Photonics</keyword> will merge with the <keyword id="1817616" type="ORGANIZATION" weightage="60" keywordseo="SPAC">SPAC</keyword> known as <keyword id="10958989" type="UNKNOWN" weightage="60" keywordseo="sc-health-corp-">SC Health Corp.</keyword></li><li>The deal will give the combined company a pro forma enterprise value of $1.2 billion.</li><li>Rockley Photonics produces "clinic on the wrist" technology for non-invasive health monitoring.</li></ul>Rockley Photonics is set to merge with the SPAC SC Health Corp. in a deal that will give the combined company a pro forma enterprise value of $1.2 billion.The <keyword id="42411" type="PERSON" weightage="60" keywordseo="Merger">merger</keyword> transaction will produce $323 million of gross proceeds for the combined entity and includes a fully committed $150 million PIPE. The PIPE is backed by institutional investors like Senvest Management and UBS O'Connor along with the medical device company Medtronic.Post merger, the combined company will trade on the New York Stock Exchange under the symbol "<keyword id="10958990" type="UNKNOWN" weightage="60" keywordseo="rkly">RKLY</keyword>." Existing Rockley shareholders will roll 100% of their equity into the combined company and the transaction is expected to close in the second quarter of 2021 after regulatory approval.Rockley Photonics was founded in 2013 by Dr. Andrew Rickman, the founder of the first commercial silicon photonics company, Bookham Technology. Since then, the company has become a leading global supplier of integrated silicon photonic chips and modules.Rockley produces what it calls <a href="https://rockleyphotonics.com/applications/">"clinic-on-the-wrist"</a> sensing technology that allows for non-invasive health and wellness monitoring of biomarkers like glucose, hydration, blood pressure, and more.Dr. Andrew Rickman, Rockley's founder and now CEO - who will remain as CEO and chairman after the deal- commented on the merger:"Our partnership with SC Health positions us to accelerate our time-to-market for our compelling health and wellness solutions," he said. "Our proven sensor technology, world-class partners and a relentless focus on execution will enable Rockley to deliver life-changing benefits to an enormous number of people."Rickman continued: "We believe that bringing laboratory diagnostics to the wrist will transform patient monitoring, healthcare delivery, and overall consumer health and wellbeing."

Rockley Photonics is set to merge with the SPAC SC Health Corp. in a $1.2 billion deal

You Searched For "rockley photonics" and got 2 results

Noninvasive blood glucose testing is among the new Apple Watch tech that reportedly reaches 'Proof-of Concept' stage

Rahul Verma

Rockley Photonics is set to merge with the SPAC SC Health Corp. in a $1.2 billion deal

Will Daniel

Popular Keywords

Buying Guides